Lobbying disclosures · Lobbying report
MCK: second_quarter 2026 lobbying report
Issues related to the pharmaceutical supply chain and drug shortages. Issues related to independent physician practices and community-based care. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Follow MCK- Became public
- Jul 20, 2026, 11:28 AM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 8:10 AM EST
Why this is connected
Legal-name match: MCKESSON CORPORATION is MCKESSON CORP (https://www.sec.gov/Archives/edgar/data/927653/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/07797f6b-eb0d-4f96-86d7-eb4a9f841452/","filing_uuid":"07797f6b-eb0d-4f96-86d7-eb4a9f841452","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/07797f6b-eb0d-4f96-86d7-eb4a9f841452/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Teresa Schofield","dt_posted":"2026-07-20T11:28:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"607 - 14th Street NW","registrant_address_2":"Suite 750","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":320918,"url":"https://lda.gov/api/v1/registrants/320918/","house_registrant_id":39554,"name":"KOUNTOUPES DENHAM CARR & REID, LLC","description":"Federal lobbying and consulting services","address_1":"607 - 14th Street NW","address_2":"Suite 750","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NANCY HARPER MARLOW","contact_telephone":"+1 202-803-4585","dt_updated":"2026-07-22T14:29:32.717701-04:00"},"client":{"id":65247,"url":"https://lda.gov/api/v1/clients/65247/","client_id":65247,"name":"MCKESSON CORPORATION","general_description":"Health care distribution company","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-02-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to the pharmaceutical supply chain and drug shortages. Issues related to independent physician practices and community-based care.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144880,"prefix":null,"prefix_display":null,"first_name":"LESLIE","nickname":null,"middle_name":null,"last_name":"ZELENKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":45200,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"DENHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141462,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"DEE","last_name":"BEAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10646,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"HERSHEY","last_name":"CARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":45200,"prefix":null,"prefix_display":null,"first_name":"LORI","nickname":null,"middle_name":null,"last_name":"DENHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":10646,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"HERSHEY","last_name":"CARR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141462,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"DEE","last_name":"BEAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144880,"prefix":null,"prefix_display":null,"first_name":"LESLIE","nickname":null,"middle_name":null,"last_name":"ZELENKO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Price change after we could observe it
-0.25% MCK
Adjusted closing prices from Nov 11, 2026 to Nov 12, 2026. SPY changed -0.35% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.
Congressional trading in MCK
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 15, 2026$1K–$15K
Rep. Jonathan L. Jackson (D-IL-1)
$1K–$15K · Traded Jun 15, 2026 · disclosed Jul 15, 2026 · Spouse
- Jul 12, 2026$1K–$15K
- Jul 8, 2026$1K–$15K
Rep. Ritchie Torres (D-NY-15)
$1K–$15K · Traded Jan 7, 2025 · disclosed Jul 8, 2026 · filed 547 days later
- May 1, 2026$1K–$15K
Rep. Lizzie Fletcher (D-TX-7)
$1K–$15K · Traded Apr 8, 2026 · disclosed May 1, 2026
Committee overlap: Energy and CommerceGot $10K from the company’s PAC - Mar 2, 2026$15K–$50K
Sen. Markwayne Mullin (R-OK)
$15K–$50K · Traded Feb 4, 2026 · disclosed Mar 2, 2026 · Joint
- Feb 4, 2026$15K–$50K
Sen. Markwayne Mullin (R-OK)
$15K–$50K · Traded Jan 5, 2026 · disclosed Feb 4, 2026 · Spouse
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.